Cargando…
Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy
Introduction. Nonpharmacological treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) comprises surgical myectomy (SME), alcohol septal ablation (ASA), and dual-chamber (DDD) pacing. The aim of the study was to compare the long-term effect of DDD pacing and ASA in symptomatic HO...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844225/ https://www.ncbi.nlm.nih.gov/pubmed/24319378 http://dx.doi.org/10.1155/2013/629650 |
_version_ | 1782293139376046080 |
---|---|
author | Krejci, Jan Gregor, Pavel Zemanek, David Vyskocilova, Klaudia Curila, Karol Stepanova, Radka Novak, Miroslav Groch, Ladislav Veselka, Josef |
author_facet | Krejci, Jan Gregor, Pavel Zemanek, David Vyskocilova, Klaudia Curila, Karol Stepanova, Radka Novak, Miroslav Groch, Ladislav Veselka, Josef |
author_sort | Krejci, Jan |
collection | PubMed |
description | Introduction. Nonpharmacological treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) comprises surgical myectomy (SME), alcohol septal ablation (ASA), and dual-chamber (DDD) pacing. The aim of the study was to compare the long-term effect of DDD pacing and ASA in symptomatic HOCM patients. Patients and Methods. We evaluated retrospective data from three cardiocenters; there were 24 patients treated with DDD pacing included and 52 treated with ASA followed for 101 ± 49 and 87 ± 23 months, respectively. Results. In the group treated with DDD pacing, the left ventricle outflow tract gradient (LVOTG) decreased from 82 ± 44 mmHg to 21 ± 21 mmHg, and NYHA class improved from 2.7 ± 0.5 to 2.1 ± 0.6 (both P < 0.001). In the ASA-treated group, a decline in LVOTG from 73 ± 38 mmHg to 24 ± 26 mmHg and reduction in NYHA class from 2.8 ± 0.5 to 1.7 ± 0.8 were observed (both P < 0.001). The LVOTG change was similar in both groups (P = 0.264), and symptoms were more affected by ASA (P = 0.001). Conclusion. ASA and DDD pacing were similarly effective in reducing LVOTG. The symptoms improvement was more expressed in patients treated with ASA. |
format | Online Article Text |
id | pubmed-3844225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38442252013-12-08 Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy Krejci, Jan Gregor, Pavel Zemanek, David Vyskocilova, Klaudia Curila, Karol Stepanova, Radka Novak, Miroslav Groch, Ladislav Veselka, Josef ScientificWorldJournal Clinical Study Introduction. Nonpharmacological treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) comprises surgical myectomy (SME), alcohol septal ablation (ASA), and dual-chamber (DDD) pacing. The aim of the study was to compare the long-term effect of DDD pacing and ASA in symptomatic HOCM patients. Patients and Methods. We evaluated retrospective data from three cardiocenters; there were 24 patients treated with DDD pacing included and 52 treated with ASA followed for 101 ± 49 and 87 ± 23 months, respectively. Results. In the group treated with DDD pacing, the left ventricle outflow tract gradient (LVOTG) decreased from 82 ± 44 mmHg to 21 ± 21 mmHg, and NYHA class improved from 2.7 ± 0.5 to 2.1 ± 0.6 (both P < 0.001). In the ASA-treated group, a decline in LVOTG from 73 ± 38 mmHg to 24 ± 26 mmHg and reduction in NYHA class from 2.8 ± 0.5 to 1.7 ± 0.8 were observed (both P < 0.001). The LVOTG change was similar in both groups (P = 0.264), and symptoms were more affected by ASA (P = 0.001). Conclusion. ASA and DDD pacing were similarly effective in reducing LVOTG. The symptoms improvement was more expressed in patients treated with ASA. Hindawi Publishing Corporation 2013-11-11 /pmc/articles/PMC3844225/ /pubmed/24319378 http://dx.doi.org/10.1155/2013/629650 Text en Copyright © 2013 Jan Krejci et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Krejci, Jan Gregor, Pavel Zemanek, David Vyskocilova, Klaudia Curila, Karol Stepanova, Radka Novak, Miroslav Groch, Ladislav Veselka, Josef Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy |
title | Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy |
title_full | Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy |
title_fullStr | Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy |
title_full_unstemmed | Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy |
title_short | Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy |
title_sort | comparison of long-term effect of dual-chamber pacing and alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844225/ https://www.ncbi.nlm.nih.gov/pubmed/24319378 http://dx.doi.org/10.1155/2013/629650 |
work_keys_str_mv | AT krejcijan comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy AT gregorpavel comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy AT zemanekdavid comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy AT vyskocilovaklaudia comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy AT curilakarol comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy AT stepanovaradka comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy AT novakmiroslav comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy AT grochladislav comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy AT veselkajosef comparisonoflongtermeffectofdualchamberpacingandalcoholseptalablationinpatientswithhypertrophicobstructivecardiomyopathy |